Daniel T. Scavilla - 11 Mar 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: President, CEO & Member of BOD, Director
Issuer ticker: XRAY
Reported as of: 11 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Mar 2026, 17:44:35 UTC
Prior SEC filing: 06 Mar 2026
Next SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla

Key filing fact

Daniel T. Scavilla filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 12 Mar 2026.

Key facts

This page summarizes Daniel T. Scavilla's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Mar 2026, 17:44.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001642439 Primary reporting owner

Scavilla Daniel T

Relationship: President, CEO & Member of BOD, Director
Address: C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla
Signature date: 12 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Phantom Stock (Supplemental Executive Retirement Plan) SERP

Award

Transaction value
Shares: +3,555
Change %
Price: $11.43^*
Shares after: 3,555
Date: 11 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,555
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

Footnote F2

Comprised of phantom stock.

Footnote F3

Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.